176 related articles for article (PubMed ID: 19448114)
41. Accuracy of diffusion-weighted echo-planar MR imaging and ADC mapping in the evaluation of residual cervical carcinoma after radiation therapy.
Levy A; Caramella C; Chargari C; Medjhoul A; Rey A; Zareski E; Boulet B; Bidault F; Dromain C; Balleyguier C
Gynecol Oncol; 2011 Oct; 123(1):110-5. PubMed ID: 21764110
[TBL] [Abstract][Full Text] [Related]
42. Magnetic resonance diffusion-weighted imaging: extraneurological applications.
Colagrande S; Carbone SF; Carusi LM; Cova M; Villari N
Radiol Med; 2006 Apr; 111(3):392-419. PubMed ID: 16683086
[TBL] [Abstract][Full Text] [Related]
43. Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors.
Dağgülli M; Onur MR; Fırdolaş F; Onur R; Kocakoç E; Orhan İ
Urol Int; 2011; 87(3):346-52. PubMed ID: 21934281
[TBL] [Abstract][Full Text] [Related]
44. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T.
Lin G; Ho KC; Wang JJ; Ng KK; Wai YY; Chen YT; Chang CJ; Ng SH; Lai CH; Yen TC
J Magn Reson Imaging; 2008 Jul; 28(1):128-35. PubMed ID: 18581404
[TBL] [Abstract][Full Text] [Related]
45. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
[TBL] [Abstract][Full Text] [Related]
46. [The value of MRI in staging gynecologic tumors].
Lorenzen M
Aktuelle Radiol; 1996 Mar; 6(2):63-8. PubMed ID: 8679726
[TBL] [Abstract][Full Text] [Related]
47. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
48. Diffusion weighted MR imaging (DWI) and ADC values in endometrial carcinoma.
Masroor I; Zeeshan M; Afzal S; Ahmad N; Shafqat G
J Coll Physicians Surg Pak; 2010 Nov; 20(11):709-13. PubMed ID: 21078241
[TBL] [Abstract][Full Text] [Related]
49. Staging of uterine cervical carcinoma: whole-body diffusion-weighted magnetic resonance imaging.
Chen YB; Hu CM; Chen GL; Hu D; Liao J
Abdom Imaging; 2011 Oct; 36(5):619-26. PubMed ID: 20730423
[TBL] [Abstract][Full Text] [Related]
50. Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components.
Li W; Chu C; Cui Y; Zhang P; Zhu M
Abdom Imaging; 2012 Oct; 37(5):897-903. PubMed ID: 22038329
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of diagnostic effectiveness of the method of diffusion-weighted MR-images in diagnosis of pathology of the uterine body].
Stolyarova IV; Yakovleva EK; Sharakova VV
Vopr Onkol; 2015; 61(6):986-93. PubMed ID: 26995993
[TBL] [Abstract][Full Text] [Related]
52. Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy.
Sepahdari AR; Aakalu VK; Setabutr P; Shiehmorteza M; Naheedy JH; Mafee MF
Radiology; 2010 Aug; 256(2):554-64. PubMed ID: 20656840
[TBL] [Abstract][Full Text] [Related]
53. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
[TBL] [Abstract][Full Text] [Related]
54. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.
Curvo-Semedo L; Lambregts DM; Maas M; Thywissen T; Mehsen RT; Lammering G; Beets GL; Caseiro-Alves F; Beets-Tan RG
Radiology; 2011 Sep; 260(3):734-43. PubMed ID: 21673229
[TBL] [Abstract][Full Text] [Related]
55. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.
Thoeny HC; De Keyzer F; Vandecaveye V; Chen F; Sun X; Bosmans H; Hermans R; Verbeken EK; Boesch C; Marchal G; Landuyt W; Ni Y
Radiology; 2005 Nov; 237(2):492-9. PubMed ID: 16192323
[TBL] [Abstract][Full Text] [Related]
56. The value of 3.0Tesla diffusion-weighted MRI for pelvic nodal staging in patients with early stage cervical cancer.
Klerkx WM; Veldhuis WB; Spijkerboer AM; van den Bosch MA; Mali WP; Heintz AP; Bipat S; Sie-Go DM; van der Velden J; Schreuder HW; Stoker J; Peeters PH
Eur J Cancer; 2012 Dec; 48(18):3414-21. PubMed ID: 22835781
[TBL] [Abstract][Full Text] [Related]
57. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
[TBL] [Abstract][Full Text] [Related]
58. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging.
Kinkel K; Ariche M; Tardivon AA; Spatz A; Castaigne D; Lhomme C; Vanel D
Radiology; 1997 Jul; 204(1):55-63. PubMed ID: 9205223
[TBL] [Abstract][Full Text] [Related]
59. Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer.
Kyriazi S; Collins DJ; Morgan VA; Giles SL; deSouza NM
Radiographics; 2010 Sep; 30(5):1269-85. PubMed ID: 20833850
[TBL] [Abstract][Full Text] [Related]
60. Imaging of Endometrial Cancer.
Sbarra M; Lupinelli M; Brook OR; Venkatesan AM; Nougaret S
Radiol Clin North Am; 2023 Jul; 61(4):609-625. PubMed ID: 37169427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
